Mozambique
Deep-built48% circumcision prevalence
Prevalence of non-therapeutic male circumcision.
Research coverage
A transparent snapshot of what this file currently contains.
8
Sources · Citations
8
Verifications · Independent
5
Structured claims · Evidence-based
Jul 9, 2026
Last updated · deep-built
Research note: Mozambique — built June 2026 deep-research burst (wf_a6911890-ee2): the NORTH/SOUTH SPLIT case. 48% (2011 DHS, 95% CI 46.5-49.5, men 15+; no post-2011 nationally representative survey) masking near-universal Yao Muslim NORTH (jando initiation, ages 8-14, July-Sept, ndagala secrecy — documented primarily from Malawi Yao literature, Mozambique-specific limited, explicitly flagged) vs historically non-circumcising Shona/Tsonga SOUTH (7 VMMC priority provinces, 27% baseline 2009). VMMC: NMCS 2013-17 targeted 2M males 10-49; 811,937 VMMCs 2017-2021 (62.5-90.9% annual targets; Chókwè 15-24 cohort 90.2% by 2019); 51.5% VMMC clients under 15 (tradition-aligned). SAFETY: PrePex pilot José Macamo 504 males — 1.0% overall AEs but 59.5% removal pain (device-specific); AE undercount 8.3× gap (Gimbel et al., 16 clinics: 0.15%→5.9%). HARM: HONEST GAP — 0 jando-setting cases indexed for Mozambique → INCIDENTS=[]. HIV: ~12.6% adult; one of 14 VMMC priority countries; no circ↔HIV causal claim; combination prevention. UNREGULATED — no statute on male circ (absence-of-evidence). FGM: present some northern provinces, STRICTLY SEPARATE. Filled: M1 (48% DHS 2011), M2 (HIV 12.6%), P1-P4, H1 (write-up), L1/L3/L4 (UNREGULATED), S1/S2 (8 graded sources #827-834), 5 claims, 0 incidents (honest gap). DEEP_BUILT.
Research claims
Short, testable claims backed by evidence and categorised for clarity.
Mozambique 48% national prevalence (2011 DHS) masks near-universal Yao north vs non-circumcising south
Mozambique's national male circumcision prevalence of 48% (95% CI 46.5–49.5 among men 15+, 2011 DHS, PMC10936832) masks a fundamental geographic divide: near-universal circumcision in the Yao Muslim communities of Niassa/Cabo Delgado/Nampula provinces (north) vs historically low circumcision in the Shona/Tsonga-related communities of the southern provinces (VMMC target regions, 27% baseline 2009). VMMC scale-up since 2013 has raised coverage in the southern priority provinces; no post-2011 nationally representative figure was confirmed in verified claims.
MEDIUM confidence: 2011 DHS is the last nationally representative male circumcision survey for Mozambique confirmed in indexed literature. VMMC has likely raised the national figure post-2011. The exact northern provincial prevalence is not quantified in verified claims.
Mozambique NMCS: 811,937 VMMCs 2017-2021 targeting 7 historically non-circumcising provinces
Mozambique's 2013-2017 National Male Circumcision Strategy (NMCS) targeted 2 million males aged 10-49 across 7 priority provinces with high HIV incidence and low baseline circumcision (Maputo City, Maputo Province, Gaza, Zambezia, Manica, Tete, Sofala), rising to an 80% coverage target under PEN IV (2019). VMMC delivered 2017-2021: 811,937 procedures total (2017: 189,225 / 62.5%; 2018: 233,069 / 90.9%; 2019: 222,887 / 83.1%; 2020: 120,464 / 42.9% COVID-impacted; 2021: 46,292 / 84.3%). Chókwè District 15-24 cohort: 90.2% by 2019, exceeding the national 80% target for that age group. 51.5% of Mozambique VMMC clients were under age 15 — consistent with the tradition-aligned jando starting age.
Annual targets and volumes from CDC MMWR (primary government source). The 90.2% Chókwè cohort figure is district-specific, not national. The refuted 42-percentage-point increase claim (0-3) is excluded.
Yao jando initiation circumcision in northern Mozambique: ages 10-14, July-Sept, ndagala secrecy
Yao communities in northern Mozambique (Niassa/Cabo Delgado/Nampula provinces) practice traditional initiation circumcision as part of the jando ceremony — ages 8-14, held July through late September, in bush seclusion camps called ndagala, under strict secrecy norms that historically excluded uncircumcised males, women, and the initiates' own mothers. The jando functions as a cultural-moral formation rite: Yao communities articulate it as moral-character development, not biomedical protection. The Mozambique-specific jando documentation in indexed English-language literature is limited; the best available evidence comes from peer-reviewed studies of Malawian Yao communities, extrapolated given the Yao people's colonial-border split between Mozambique and Malawi.
MODERATE confidence overall; the jando ceremony structure (ages, timing, secrecy, ndagala camp) is HIGH confidence from Malawi-based peer-reviewed sources (PMC4433597, PMC10645834). Its applicability to northern Mozambican Yao communities is a reasonable extrapolation given the shared Yao ethnic identity, but not confirmed by a Mozambique-specific primary source — explicitly flagged.
Mozambique HIV ~12.6% adult — VMMC one component of combination prevention; no causal claim
Mozambique's adult HIV prevalence is approximately 12.6% (UNAIDS 2024; among the highest in sub-Saharan Africa). Mozambique is one of the 14 WHO/UNAIDS VMMC priority countries. VMMC is one component of combination HIV prevention (alongside ART scale-up, condom promotion, PrEP); isolating VMMC's independent contribution to HIV-incidence changes is methodologically challenging given concurrent interventions. WHO/UNAIDS describe VMMC as approximately 60% effective in preventing female-to-male HIV transmission (from three African RCTs, South Africa/Kenya/Uganda) — the stated basis for the priority programme. No circ↔HIV causal claim is made for Mozambique.
The 60% RCT efficacy estimate applies to female-to-male heterosexual transmission only; real-world effectiveness estimates from observational studies suggest ~50-56%. Early trial stopping can inflate RCT effect estimates. No circ↔HIV causal claim.
PrePex pilot Maputo: 1.0% overall AEs but 59.5% moderate/severe pain at device removal
The Mozambique PrePex device pilot at José Macamo General Hospital, Maputo enrolled 504 males aged 18-49. Overall moderate/severe AEs: 1.0% (5/504). However, 59.5% (300/504) experienced moderate or severe pain specifically at the device removal step — a major safety signal documented by the authors as requiring improved analgesia protocols. 84.2% achieved complete wound healing by day 49. Procedures were nurse-performed with surgical backup. This removal-pain finding does not apply to surgical VMMC methods and should not be conflated with surgical AE rates.
Device-specific finding (PrePex clamp/ring device). Not applicable to surgical VMMC. A separate VMMC AE undercount study (Gimbel et al., 16 clinics) documented an 8.3-fold gap between official (0.15%) and prospectively observed (5.9%) AE rates in Mozambique — raising surveillance quality concerns independent of the PrePex pilot.
Legal status
UnregulatedMozambique has no confirmed statute specifically regulating or prohibiting non-therapeutic male circumcision. The practice is legally unrestricted — an absence-of-evidence finding. VMMC is supported by the Ministry of Health through the National Male Circumcision Strategy and PEN IV targets; this is a policy/programme framework, not a legal statute on circumcision per se. FGM is a completely separate female practice; some Mozambican provinces have FGC practices, but the legal treatment of FGM in Mozambique was not confirmed in the verified research pass — disambiguation only.
No Mozambican statute specifically regulating, permitting, or prohibiting non-therapeutic male circumcision was located in the verified research pass. The Ministry of Health supports VMMC through the 2013-2017 National Male Circumcision Strategy (NMCS) and PEN IV (80% target by 2019) — these are policy frameworks, not legislation. Absence of a prohibiting statute is not a positive permission, but merely confirms the practice is not specially regulated. FGM (female genital mutilation/cutting) is a completely separate female practice and legal category. Some northern Mozambican provinces have FGC practices among certain communities; the legal framework governing FGM in Mozambique (whether criminalised or not) was not confirmed in verified claims — strictly separate and not conflated with male circumcision.
Medical & HIV context
12.6%
Adult HIV prevalence
UNAIDS (2024) · Adults 15–49
not-infant
Circumcision in newborns
Non-therapeutic (cultural practice)
NORTH (Yao Muslim communities — Niassa/Cabo Delgado/Nampula): traditional jando initiation, ages 10–14, conducted July–late September in bush seclusion camps. SOUTH (7 priority provinces — Maputo City/Province/Gaza/Zambezia/Manica/Tete/Sofala): VMMC programme targets ages 10–49, shifting toward adolescents (51.5% of Mozambique VMMC clients under age 15 as of 2017–2021, consistent with the jando starting-age tradition). National figure (48%, 2011 DHS) masks this regional split.
Typical age
Benchmarks are international context — not a local complication rate.
Incident registry
No verified incidents are currently recorded for Mozambique.
This absence should not be read as proof that harm does not occur — only that no verified, sourced case has been documented in this database yet.